Complications | Totala (60) | Early-onset (25) | Late-onset (30) | P valuef | |||
---|---|---|---|---|---|---|---|
n | % | n | % | Â | % | ||
Skin lesions | 19 | 31.7 | 7 | 28.0 | 12 | 40.0 | 0.351 |
Neurological involvement | Â | Â | Â | Â | Â | Â | Â |
 Intellectual disability | 36 | 60.0 | 16 | 64.0 | 20 | 66.7 | 0.836 |
 Seizures | 25 | 41.7 | 8 | 32.0 | 17 | 56.7 | 0.114 |
 Hearing impairmentb | 3 | 5.0 | 1 | 4.0 | 2 | 6.7 | 1.000 |
Hematological abnormalities | Â | Â | Â | Â | Â | Â | Â |
 Anemia | 23 | 38.3 | 12 | 48.0 | 10 | 33.3 | 0.269 |
 Pancytopenia | 9 | 15.0 | 5 | 20.0 | 4 | 13.3 | 0.765 |
 Thrombocytopenia | 2 | 3.3 | 2 | 8.0 | 0 | 0 | 0.202 |
Digestive system abnormalities | Â | Â | Â | Â | Â | Â | Â |
 Intermittent vomiting | 18 | 30.0 | 5 | 20.0 | 12 | 40.0 | 0.110 |
 Liver involvementc | 14 | 25.0 | 7 | 28.0 | 7 | 23.3 | 0.692 |
Renal dysfunctiond | 2 | 3.3 | 2 | 8.0 | 0 | 0 | 0.202 |
Cardiac diseasese | 4 | 6.7 | 1 | 4.0 | 3 | 10.0 | 1.000 |
Death | 9 | 15.0 | 7 | 28.0 | 2 | 6.7 | 0.078 |
Age at the last follow-up (years, median and range) | 3.0 (0.2–19.0) | 1.4 (0.2–10.0) | 3.3 (0.7–19.0) | 0.021 |